AVIVA PLC - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 24 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
AVIVA PLC ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,583,012
-1.0%
23,000,000
+27.8%
0.06%
+1.7%
Q2 2023$14,728,950
-16.6%
18,000,0000.0%0.06%
-25.0%
Q1 2023$17,662,122
+29.6%
18,000,000
+20.0%
0.08%
+19.4%
Q4 2022$13,626,000
-10.5%
15,000,0000.0%0.07%
-23.9%
Q3 2022$15,225,000
+1.3%
15,000,0000.0%0.09%
+10.0%
Q2 2022$15,036,000
-4.9%
15,000,0000.0%0.08%
+1.3%
Q1 2022$15,810,00015,000,0000.08%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 45,000,000$474,089,0009.50%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,000,000$4,280,0000.96%
DeepCurrents Investment Group LLC 22,150,000$23,650,0000.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 19,000,000$19,967,0000.46%
Context Capital Management, LLC 5,750$6,138,0000.40%
WOLVERINE ASSET MANAGEMENT LLC 34,000,000$36,271,0000.35%
Polar Asset Management Partners Inc. 15,000,000$15,993,0000.17%
LINDEN ADVISORS LP 20,000,000$21,281,0000.13%
Wellesley Asset Management 1,599$1,599,0000.11%
Verition Fund Management LLC 6,213,000$6,614,0000.08%
View complete list of TRAVERE THERAPEUTICS INC shareholders